Status:
RECRUITING
Quadratus Lumborum Block for Total Hip Arthroplasty
Lead Sponsor:
University of California, Los Angeles
Conditions:
Pain, Postoperative
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
The quadratus lumborum (QL) block is a fascial plane block that has been described to provide analgesia from T7-L3 dermatomes. The investigators aim to evaluate the efficacy of QL blocks in patients u...
Detailed Description
Investigators will enroll subjects planned for primary THA and allocate them into receiving a QL block with either saline or ropivacaine. Primary outcome will be pain scores over the first 48 hours af...
Eligibility Criteria
Inclusion
- Adult subjects undergoing elective primary total hip arthroplasty
Exclusion
- patients age \< 18,
- documented allergy to local anesthetic
- presence of peripheral neuropathy
- patients with current long term opioid use defined as receiving an opioid on most days in a 90 day period
- patients with a contraindication to spinal and regional anesthesia such as coagulopathy or infection at the site of the regional technique.
Key Trial Info
Start Date :
March 29 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05247255
Start Date
March 29 2022
End Date
January 1 2027
Last Update
December 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Medical Center, Santa Monica
Santa Monica, California, United States, 90404